<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cision Wire</title>
    <link>http://news.cision.com/</link>
    <description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description>
    <pubDate>Sat, 18 May 2013 22:29:37 GMT</pubDate>
    <image>
      <title>Cision Wire</title>
      <width>120</width>
      <height>32</height>
      <link>http://news.cision.com/</link>
      <url>http://news.cision.com/ui/images/CisionLogoSmall.gif</url>
    </image>
    <item>
      <title>Market Making agreement with Norne Securities</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/market-making-agreement-with-norne-securities,e373315</link>
      <guid isPermaLink="false">cision1323771</guid>
      <description><![CDATA[]]></description>
      <pubDate>Mon, 06 May 2013 13:02:40 GMT</pubDate>
    </item>
    <item>
      <title>MenaQ7&amp;#174; Natural Vitamin K Chosen as Finalist for Nutrition Business Technology Awar</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/menaq7-174--natural-vitamin-k-chosen-as-finalist-for-nutrition-business-technology-awar,e369300</link>
      <guid isPermaLink="false">cision1307989</guid>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 19 Apr 2013 07:20:34 GMT</pubDate>
    </item>
    <item>
      <title>MenaQ7&amp;#174; brand Vitamin K2 Shown More Potent than K1in New Human Stud</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/menaq7-174--brand-vitamin-k2-shown-more-potent-than-k1in-new-human-stud,e365835</link>
      <guid isPermaLink="false">cision1291620</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 03 Apr 2013 07:01:10 GMT</pubDate>
    </item>
    <item>
      <title>NattoPharma's MenaQ7&amp;#174; to significantly reduce bone loss and risk for osteoporosis: Significant commercial opportunitie</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/nattopharma-s-menaq7-174--to-significantly-reduce-bone-loss-and-risk-for-osteoporosis--significant-c,e365029</link>
      <guid isPermaLink="false">cision1286313</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 27 Mar 2013 08:42:39 GMT</pubDate>
    </item>
    <item>
      <title>MenaQ7&amp;#174; brand Vitamin K2 intake prevents bone loss and improves bone impact strength in postmenopausal wome</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/menaq7-174--brand-vitamin-k2-intake-prevents-bone-loss-and-improves-bone-impact-strength-in-postmeno,e364661</link>
      <guid isPermaLink="false">cision1284845</guid>
      <description><![CDATA[]]></description>
      <pubDate>Tue, 26 Mar 2013 08:29:04 GMT</pubDate>
    </item>
    <item>
      <title>Oslo B&amp;#248;rs - NATTO S - Last day of listing today</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/oslo-b-248-rs---natto-s---last-day-of-listing-today,e346351</link>
      <guid isPermaLink="false">cision1198855</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 12 Dec 2012 10:03:26 GMT</pubDate>
    </item>
    <item>
      <title>The subscription rights in the quoted company NattoPharma ASA will be listed 03.12.2012</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/the-subscription-rights-in-the-quoted-company-nattopharma-asa-will-be-listed-03-12-2012,e344722</link>
      <guid isPermaLink="false">cision1188324</guid>
      <description><![CDATA[]]></description>
      <pubDate>Mon, 03 Dec 2012 07:52:39 GMT</pubDate>
    </item>
    <item>
      <title>The subscription rights in the quoted company NattoPharma ASA will be listed 03.12.2012</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/the-subscription-rights-in-the-quoted-company-nattopharma-asa-will-be-listed-03-12-2012,e344574</link>
      <guid isPermaLink="false">cision1187727</guid>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 30 Nov 2012 14:03:20 GMT</pubDate>
    </item>
    <item>
      <title>Financial calendar 2013</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/financial-calendar-2013,e344555</link>
      <guid isPermaLink="false">cision1187670</guid>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 30 Nov 2012 13:22:20 GMT</pubDate>
    </item>
    <item>
      <title>Ex subscription right today 28.11.2012</title>
      <link>http://news.cision.com/nattopharma-asa-ob/r/ex-subscription-right-today-28-11-2012,e343832</link>
      <guid isPermaLink="false">cision1184590</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 28 Nov 2012 07:26:33 GMT</pubDate>
    </item>
  </channel>
</rss>